Ga733/EpCAM as a Target for Passive and Active Specific Immunotherapy in Patients with Colorectal CarcinomaH. MELLSTEDT; J. FAGERBERG; J-E. FRÖDIN; A-L. HJELM-SKOG; M. LILJEFORS; K. MARKOVIC; S. MOSOLITS; P. RAGNHAMMAR · 2000

466 DUTASTERIDE PLUS TAMSULOSIN PROVIDES SUPERIOR AND CLINICALLY RELEVANT IMPROVEMENTS IN SYMPTOMS AND QOL: 2-YEAR RESULTS FROM THE COMBINATION OF AVODART® AND TAMSULOSIN (COMBAT) STUDYA. Tubaro; J. Extramiana; W. Hölzer; J.C. Alimi; T. Wilson; L. Black; S. Mosolits; R. Castro · 2009

Vaccination with Ep-CAM Protein or Anti-Idiotypic Antibody Induces Th1-Biased Response against MHC Class I- and II-Restricted Ep-CAM Epitopes in Colorectal Carcinoma PatientsMosolits, S. · Clinical Cancer Research · 2004

Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.Kattan, J; Culine, S; Terrier-Lacombe, M J; Theodore, C; Droz, J P · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1993

Combination immunotherapy approachesDrake, C. G. · Annals of Oncology · 2012

Advances in immuno-oncologyEggermont, A.; Finn, O. · Annals of Oncology · 2012

Thanks to referees 2011Annals of Oncology · 2012

OsteosarcomaRitter, J.; Bielack, S. S. · Annals of Oncology · 2010

The role of chemotherapy in cholangiocarcinomaThongprasert, S. · Annals of Oncology · 2005

Spirituality in the cancer trajectoryPuchalski, C. M. · Annals of Oncology · 2012

New insights into pancreatic cancer biologyHidalgo, M. · Annals of Oncology · 2012